IRONWOOD PHARMACEUTICALS, INC. Basic Shares Outstanding (Weighted Average)
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Basic Shares Outstanding (Weighted Average) of 164.41 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 164.41M shares, a 1.66% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 163.45M shares, a 1.54% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 162.44M shares, a 1.59% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 162.22M shares, a 1.57% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 161.84M shares, a 1.73% increase from fiscal 2024.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 159.08M shares, a 2.35% increase from fiscal 2023.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 155.44M shares, a 0.69% increase from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 154.37M shares, a 4.86% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 164.41M shares 10-Q · filed 2026-08-06 | 163.93M shares 10-Q · filed 2026-08-06 | 163.43M shares derived: average of 3 quarters · filed 2026-08-06 | 163.13M shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | 163.45M shares 10-Q · filed 2026-05-07 | 162.95M shares derived: average of 2 quarters · filed 2026-05-07 | 162.70M shares derived: average of 3 quarters · filed 2026-05-07 | 162.46M shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | 162.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 162.33M shares derived: average of 2 quarters · filed 2026-02-26 | 162.13M shares derived: average of 3 quarters · filed 2026-08-06 | 161.84M shares 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 162.22M shares 10-Q · filed 2025-11-10 | 161.97M shares derived: average of 2 quarters · filed 2026-08-06 | 161.64M shares 10-Q · filed 2025-11-10 | 161.20M shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | 161.72M shares 10-Q · filed 2026-08-06 | 161.35M shares 10-Q · filed 2026-08-06 | 160.87M shares derived: average of 3 quarters · filed 2026-08-06 | 160.58M shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | 160.97M shares 10-Q · filed 2026-05-07 | 160.44M shares derived: average of 2 quarters · filed 2026-05-07 | 160.19M shares derived: average of 3 quarters · filed 2026-05-07 | 159.90M shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | 159.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 159.80M shares derived: average of 2 quarters · filed 2026-02-26 | 159.54M shares derived: average of 3 quarters · filed 2026-02-26 | 159.08M shares 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 159.71M shares 10-Q · filed 2025-11-10 | 159.36M shares derived: average of 2 quarters · filed 2025-11-10 | 158.81M shares 10-Q · filed 2025-11-10 | 158.11M shares derived: average of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | 159.01M shares 10-Q · filed 2025-08-11 | 158.36M shares 10-Q · filed 2025-08-11 | 157.58M shares derived: average of 3 quarters · filed 2025-08-11 | 157.16M shares derived: average of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | 157.70M shares 10-Q · filed 2025-05-12 | 156.86M shares derived: average of 2 quarters · filed 2025-05-12 | 156.54M shares derived: average of 3 quarters · filed 2025-05-12 | 156.24M shares derived: average of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | 156.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 155.95M shares derived: average of 2 quarters · filed 2025-03-31 | 155.76M shares derived: average of 3 quarters · filed 2025-03-31 | 155.44M shares 10-K · filed 2025-03-31 | |||
| 2023-09-30 | 155.89M shares 10-Q · filed 2024-11-07 | 155.63M shares derived: average of 2 quarters · filed 2024-11-07 | 155.24M shares 10-Q · filed 2024-11-07 | 154.76M shares derived: average of 4 quarters · filed 2025-03-31 | |||
| 2023-06-30 | 155.37M shares 10-Q · filed 2024-08-08 | 154.91M shares 10-Q · filed 2024-08-08 | 154.38M shares derived: average of 3 quarters · filed 2025-03-31 | 154.05M shares derived: average of 4 quarters · filed 2025-03-31 | |||
| 2023-03-31 | 154.45M shares 10-Q · filed 2024-05-09 | 153.89M shares derived: average of 2 quarters · filed 2025-03-31 | 153.61M shares derived: average of 3 quarters · filed 2025-03-31 | 153.54M shares derived: average of 4 quarters · filed 2025-03-31 | |||
| 2022-12-31 | 153.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 153.20M shares derived: average of 2 quarters · filed 2025-03-31 | 153.23M shares derived: average of 3 quarters · filed 2025-03-31 | 154.37M shares 10-K · filed 2025-03-31 | |||
| 2022-09-30 | 153.07M shares 10-Q · filed 2023-11-09 | 153.19M shares derived: average of 2 quarters · filed 2023-11-09 | 154.71M shares 10-Q · filed 2023-11-09 | 156.87M shares derived: average of 4 quarters · filed 2024-02-16 | |||
| 2022-06-30 | 153.30M shares 10-Q · filed 2023-08-09 | 155.55M shares 10-Q · filed 2023-08-09 | 158.14M shares derived: average of 3 quarters · filed 2024-02-16 | 159.29M shares derived: average of 4 quarters · filed 2024-02-16 | |||
| 2022-03-31 | 157.82M shares 10-Q · filed 2023-05-04 | 160.56M shares derived: average of 2 quarters · filed 2024-02-16 | 161.29M shares derived: average of 3 quarters · filed 2024-02-16 | 161.45M shares derived: average of 4 quarters · filed 2024-02-16 | |||
| 2021-12-31 | 163.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | 163.02M shares derived: average of 2 quarters · filed 2024-02-16 | 162.66M shares derived: average of 3 quarters · filed 2024-02-16 | 162.25M shares 10-K · filed 2024-02-16 | |||
| 2021-09-30 | 162.74M shares 10-Q · filed 2022-11-03 | 162.34M shares derived: average of 2 quarters · filed 2022-11-03 | 161.89M shares 10-Q · filed 2022-11-03 | 161.43M shares derived: average of 4 quarters · filed 2023-02-16 | |||
| 2021-06-30 | 161.95M shares 10-Q · filed 2022-08-04 | 161.46M shares 10-Q · filed 2022-08-04 | 161.00M shares derived: average of 3 quarters · filed 2023-02-16 | 160.71M shares derived: average of 4 quarters · filed 2023-02-16 | |||
| 2021-03-31 | 160.97M shares 10-Q · filed 2022-05-05 | 160.52M shares derived: average of 2 quarters · filed 2023-02-16 | 160.30M shares derived: average of 3 quarters · filed 2023-02-16 | 160.07M shares derived: average of 4 quarters · filed 2023-02-16 | |||
| 2020-12-31 | 160.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | 159.96M shares derived: average of 2 quarters · filed 2023-02-16 | 159.78M shares derived: average of 3 quarters · filed 2023-02-16 | 159.43M shares 10-K · filed 2023-02-16 | |||
| 2020-09-30 | 159.85M shares 10-Q · filed 2021-11-04 | 159.85K shares 10-Q · filed 2020-11-05 | 159.63M shares derived: average of 2 quarters · filed 2021-11-04 | 159.21M shares 10-Q · filed 2021-11-04 | 159.21K shares 10-Q · filed 2020-11-05 | 275.31M shares derived: average of 4 quarters · filed 2022-02-18 | |
| 2020-06-30 | 159.41M shares 10-Q · filed 2021-08-05 | 159.41K shares 10-Q · filed 2020-08-06 | 158.89M shares 10-Q · filed 2021-08-05 | 158.89K shares 10-Q · filed 2020-08-06 | 313.80M shares derived: average of 3 quarters · filed 2022-02-18 | 235.39M shares derived: average of 4 quarters · filed 2022-02-18 | |
| 2020-03-31 | 158.37M shares 10-Q · filed 2021-05-06 | 158.37K shares 10-Q · filed 2020-05-06 | 391.00M shares derived: average of 2 quarters · filed 2022-02-18 | 260.72M shares derived: average of 3 quarters · filed 2022-02-18 | 195.58M shares derived: average of 4 quarters · filed 2022-02-18 | ||
| 2019-12-31 | 623.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | 311.89M shares derived: average of 2 quarters · filed 2022-02-18 | 207.98M shares derived: average of 3 quarters · filed 2022-02-18 | 156.02M shares 10-K · filed 2022-02-18 | |||
| 2019-09-30 | 156.44K shares 10-Q · filed 2020-11-05 | 156.14K shares derived: average of 2 quarters · filed 2020-11-05 | 155.75K shares 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | 155.85K shares 10-Q · filed 2020-08-06 | 155.41K shares 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | 154.96K shares 10-Q · filed 2020-05-06 | ||||||
| 2018-12-31 | 152.63M shares 10-K · filed 2021-02-17 | ||||||
| 2013-09-30 | 120.77M shares 10-Q · filed 2013-10-28 | 114.14M shares 10-Q · filed 2013-10-28 | |||||
| 2012-09-30 | 107.27M shares 10-Q · filed 2013-10-28 | 107.17M shares derived: average of 2 quarters · filed 2013-10-28 | 106.04M shares 10-Q · filed 2013-10-28 | 104.62M shares derived: average of 4 quarters · filed 2013-10-28 | |||
| 2012-06-30 | 107.08M shares 10-Q · filed 2012-08-07 | 105.41M shares 10-Q · filed 2012-08-07 | 103.74M shares derived: average of 3 quarters · filed 2012-08-07 | 102.85M shares derived: average of 4 quarters · filed 2012-11-06 | |||
| 2012-03-31 | 103.75M shares 10-Q · filed 2012-05-10 | 102.08M shares derived: average of 2 quarters · filed 2012-05-10 | 101.44M shares derived: average of 3 quarters · filed 2012-11-06 | 101.00M shares derived: average of 4 quarters · filed 2012-11-06 | |||
| 2011-12-31 | 100.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | 100.29M shares derived: average of 2 quarters · filed 2012-11-06 | 100.08M shares derived: average of 3 quarters · filed 2012-11-06 | 99.87M shares 10-K · filed 2012-02-29 | |||
| 2011-09-30 | 100.17M shares 10-Q · filed 2012-11-06 | 99.92M shares derived: average of 2 quarters · filed 2012-11-06 | 99.70M shares 10-Q · filed 2012-11-06 | 99.41M shares derived: average of 4 quarters · filed 2012-11-06 | |||
| 2011-06-30 | 99.67M shares 10-Q · filed 2012-08-07 | 99.46M shares 10-Q · filed 2012-08-07 | 99.15M shares derived: average of 3 quarters · filed 2012-08-07 | 98.85M shares derived: average of 4 quarters · filed 2012-08-07 | |||
| 2011-03-31 | 99.08M shares 10-Q · filed 2012-05-10 | 98.89M shares derived: average of 2 quarters · filed 2012-05-10 | 98.57M shares derived: average of 3 quarters · filed 2012-05-10 | 98.34M shares derived: average of 4 quarters · filed 2012-05-10 | |||
| 2010-12-31 | 98.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | 98.32M shares derived: average of 2 quarters · filed 2012-02-29 | 98.09M shares derived: average of 3 quarters · filed 2012-02-29 | 89.65M shares 10-K · filed 2012-02-29 | |||
| 2010-09-30 | 97.93M shares 10-Q · filed 2011-11-09 | 97.78M shares derived: average of 2 quarters · filed 2011-11-09 | 86.63M shares 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | 97.64M shares 10-Q · filed 2011-08-12 | 80.89M shares 10-Q · filed 2011-08-12 | |||||
| 2009-12-31 | 7.12M shares 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |